A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+2.44%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$290M
AUM Growth
+$290M
Cap. Flow
+$22.9M
Cap. Flow %
7.92%
Top 10 Hldgs %
94.95%
Holding
17
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

1
ACET icon
Adicet Bio
ACET
$21M
2
XFOR icon
X4 Pharmaceuticals
XFOR
$1.96M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 89.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$82.1M 28.36% 4,168,718 – –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$45.1M 15.56% 1,203,135 – –
ACET icon
3
Adicet Bio
ACET
$59.9M
$21M 7.24% +1,615,385 New +$21M
VRNA
4
Verona Pharma
VRNA
$9.16B
$20.3M 7% 2,457,499 – –
SIEN
5
DELISTED
Sientra, Inc.
SIEN
$17.4M 5.99% 2,390,843 – –
NCNA
6
NuCana
NCNA
$6.09M
$16.6M 5.72% 3,333,333 – –
XCUR icon
7
Exicure
XCUR
$35.4M
$15.1M 5.23% 6,977,000 – –
SRRA
8
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$14.7M 5.08% 871,125 – –
SLNO icon
9
Soleno Therapeutics
SLNO
$3.6B
$13M 4.48% 10,302,602 – –
PRTK
10
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$7.33M 2.53% 1,041,131 – –
MTEM
11
DELISTED
Molecular Templates, Inc.
MTEM
$2.51M 0.87% 200,000 – –
XFOR icon
12
X4 Pharmaceuticals
XFOR
$84.2M
$1.96M 0.68% +229,885 New +$1.96M
SYRE icon
13
Spyre Therapeutics
SYRE
$996M
$1.9M 0.65% 240,500 – –
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
$595K 0.21% 131,036 – –
OBSV
15
DELISTED
ObsEva SA Ordinary Shares
OBSV
$286K 0.1% 87,999 – –
OCGN icon
16
Ocugen
OCGN
$319M
$48K 0.02% 7,111 – –